SMSPHARMA

SMS PHARMACEUTICALS

Small Cap BSE: 532815 NSE: SMSPHARMA
₹86.7
0.2 (0.23%)
As on 30 September, 2022 | 02:10

Sms Pharmaceuticals Share Price

Sms Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SMS PHARMACEUTICALS

Start SIP

Sms Pharmaceuticals Share Returns

  • Over 1 Month 7.65%
  • Over 3 Month 3.78%
  • Over 6 Month -9.56%
  • Over 1 Year -44.87%

Sms Pharmaceuticals Key Statistics

P/E Ratio 27.5
PEG Ratio -0.4
Market Cap Cr 734
Price to Book Ratio 1.6
EPS 8
Dividend 0.3
Relative Strength Index 50.58
Money Flow Index 81.14
MACD Signal 1.18
Average True Range 4.07

Sms Pharmaceuticals Investment Rating

  • Master Rating:
  • Sms Pharmaceuticals has an operating revenue of Rs. 421.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 13% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

SMS Pharmaceuticals Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 6461121175163171
Operating Expenses Qtr Cr 656594128119130
Operating Profit Qtr Cr 0-427474441
Depreciation Qtr Cr 888886
Interest Qtr Cr 545553
Tax Qtr Cr -3-256101012
Net Profit Qtr Cr -10911252322

Sms Pharmaceuticals Technicals

EMA & SMA

Current Price
86.55
0.05 (0.06%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 86.71
  • 50 Day
  • 85.62
  • 100 Day
  • 88.24
  • 200 Day
  • 98.18
  • 20 Day
  • 86.91
  • 50 Day
  • 85.34
  • 100 Day
  • 83.56
  • 200 Day
  • 98.1

Sms Pharmaceuticals Resistance and Support

PIVOT
₹86.97
Resistance
First Resistance 87.89
Second Resistance 89.27
Third Resistance 90.19
RSI 50.58
MFI 81.14
MACD Single Line 1.18
MACD 0.87
Support
First Resistance 85.59
Second Resistance 84.67
Third Resistance 83.29

Sms Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 29,394 1,159,887 39.46
Week 32,385 1,884,807 58.2
1 Month 133,006 6,413,542 48.22
6 Month 77,816 4,404,413 56.6

Sms Pharmaceuticals Result Highlights

SMS Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 563.18 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2021. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.
Market Cap 733
Sales 421
Shares in Float 3.05
No of funds 2
Yield 0.35
Book Value 1.48
U/D Vol ratio 1.4
LTDebt / Equity 30
Alpha -0.19
Beta 1.02

SMS Pharmaceuticals

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 64.17%67.29%67.29%
Foreign Portfolio Investors 0.63%0.61%0.65%
Individual Investors 29.65%26.38%26.71%
Others 5.55%5.72%5.35%

SMS Pharmaceuticals Management

Name Designation
Mr. Ramesh Babu Potluri Chairman & Managing Director
Mr. Vamsi Krishna Potluri Executive Director
Mr. P Sharath Kumar Independent Director
Dr.(Mrs.) T Neelaveni Independent Director
Mr. Sharvan Kudaravalli Independent Director
Mr. Sarvepalli Srinivas Independent Director
Mrs. Shilpa R Waghmare Nominee Director

Sms Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sms Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-08-13 Quarterly Results
2022-05-30 Audited Results & Final Dividend
2022-02-09 Quarterly Results
2021-11-12 Quarterly Results
2021-08-07 Quarterly Results
Date Purpose Remarks
2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend

SMS Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

SMS Pharmaceuticals FAQs

What is Share Price of SMS Pharmaceuticals ?

SMS Pharmaceuticals share price is ₹86 As on 30 September, 2022 | 01:56

What is the Market Cap of SMS Pharmaceuticals ?

The Market Cap of SMS Pharmaceuticals is ₹733.9 Cr As on 30 September, 2022 | 01:56

What is the P/E ratio of SMS Pharmaceuticals ?

The P/E ratio of SMS Pharmaceuticals is 27.5 As on 30 September, 2022 | 01:56

What is the PB ratio of SMS Pharmaceuticals ?

The PB ratio of SMS Pharmaceuticals is 1.6 As on 30 September, 2022 | 01:56

Q1FY23